Lih Anna, Pereira Lorraine, Bishay Ramy H, Zang Johnson, Omari Abdullah, Atlantis Evan, Kormas Nic
Department of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
University of New South Wales Medical Program, University of New South Wales, Sydney, NSW 2052, Australia ; Department of Vascular Medicine, St. Vincent's Hospital, Darlinghurst, Sydney, NSW 2010, Australia.
J Diabetes Res. 2015;2015:729567. doi: 10.1155/2015/729567. Epub 2015 Apr 8.
Obesity and diabetes are difficult to treat in public clinics. We sought to determine the effectiveness of the Metabolic Rehabilitation Program (MRP) in achieving long-term weight loss and improving glycaemic control versus "best practice" diabetes clinic (DC) in obese patients using a retrospective cohort study.
Patients with diabetes and BMI > 30 kg/m(2) who attended the MRP, which consisted of supervised exercise and intense allied health integration, or the DC were selected. Primary outcomes were improvements in weight and glycaemia with secondary outcomes of improvements in blood pressure and lipid profile at 12 and 30 months.
Baseline characteristics of both cohorts (40 MRP and 40 DC patients) were similar at baseline other than age (63 in MRP versus 68 years in DC, P = 0.002). At 12 months, MRP patients lost 7.65 ± 1.74 kg versus 1.76 ± 2.60 kg in the DC group (P < 0.0001) and 9.70 ± 2.13 kg versus 0.98 ± 2.65 kg at 30 months (P < 0.0001). Similarly, MRP patients had significant absolute reductions in %HbA1c at 30 months versus the DC group (-0.86 ± 0.31% versus 0.12% ± 0.33%, P < 0.038), with nonsignificant improvements in lipids and blood pressure in MRP patients.
Further research is needed to establish the MRP as an effective strategy for achieving sustained weight loss and improving glycaemic control in obese patients with type 2 diabetes.
肥胖症和糖尿病在公共诊所中难以治疗。我们试图通过一项回顾性队列研究,确定代谢康复计划(MRP)与“最佳实践”糖尿病诊所(DC)相比,在肥胖患者中实现长期体重减轻和改善血糖控制的有效性。
选择参加MRP(包括监督下的运动和强化联合健康干预)或DC的糖尿病患者且BMI>30kg/m²。主要结局是体重和血糖的改善,次要结局是12个月和30个月时血压和血脂谱的改善。
除年龄外(MRP组63岁,DC组68岁,P = 0.002),两组(40例MRP患者和40例DC患者)的基线特征在基线时相似。在12个月时,MRP组患者体重减轻7.65±1.74kg,而DC组为1.76±2.60kg(P<0.0001);在30个月时分别为9.70±2.13kg和0.98±2.65kg(P<0.0001)。同样,与DC组相比,MRP组患者在30个月时HbA1c%有显著绝对降低(-0.86±0.31%对0.12%±0.33%,P<0.038),MRP组患者血脂和血压有非显著改善。
需要进一步研究以确立MRP作为2型糖尿病肥胖患者实现持续体重减轻和改善血糖控制的有效策略。